Friday, March 24, 2023 at 2:00 pm Eastern Time
REDWOOD CITY, Calif., Feb. 23, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that D. Keith Grossman, Nevro's Chairman, CEO and President, Rod MacLeod, Chief Financial Officer, and Dr. David Caraway, Chief Medical Officer, will participate in the Wells Fargo 2023 Medtech Innovation Spotlight Call Series on Friday, March 24, 2023 at 2:00 pm Eastern Time.
Read more at prnewswire.com